BARCELONA—Image-guided adaptive brachytherapy (IGABT) for patients with cervical cancer did not increase risk for ureteral stricture (a rare but feared complication of pelvic radiotherapy) in European research reported at the European Society for Radiotherapy & Oncology (ESTRO 37) 2018 conference.
(OC-0072 Risk factors for ureteral stricture after IGABT in cervical cancer: results from the EMBRACE studies)
“Our findings show that the risks for severe to life-threatening ureteral strictures are very low in all the patients with limited stage disease,” said first author Lars Fokdal MD PhD, a clinical oncologist from Aarhus University Hospital in Denmark, who told the Audio Journal of Oncology about his group’s updated population-based findings and conclusions from analysis of data from 1772 patients treated with brachytherapy for their locally advanced cervical cancer (LACC) in the retrospective RetroEMBRACE study (with 610 patients) and the prospective EMBRACE (with 1162 patients).
